Menu Search
Equities

Athens Medical Center SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IATR:ATH

Athens Medical Center SA

Actions
  • Price (EUR)1.96
  • Today's Change-0.015 / -0.76%
  • Shares traded6.47k
  • 1 Year change-6.22%
  • Beta0.7833
Data delayed at least 20 minutes, as of Feb 06 2026 15:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Athens Medical Center SA is a Greece-based company primarily engaged in the healthcare industry. The Company is involved in the organization, operation and management of healthcare facilities, treatment centers and rehabilitation centers, either through property purchases or leases. Additionally, the Company provides training and selection of staff for healthcare units, imports and distributes medical tools and equipment, organizes supply services for necessary materials and offers financial and management consulting services. Other activities include the promotion of medical research and treatment methods, as well as the modernization of healthcare facilities. Besides its operations in Greece, Athens Medical Center SA is also active in Romania.

  • Revenue in EUR (TTM)270.92m
  • Net income in EUR-4.73m
  • Incorporated1983
  • Employees3.52k
  • Location
    Athens Medical Center SADistomou 5-7, MarousiATHINA 151 25GreeceGRC
  • Phone+30 2 106198100
  • Fax+30 2 106198555
  • Websitehttps://www.iatriko.gr/
More ▼

Institutional shareholders

3.20%Per cent of shares held by top holders
HolderShares% Held
EFG Bank AGas of 31 Dec 20242.78m3.20%
Data from 02 Jan 2026 - 02 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.